Brevan Howard Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
200,237
-4,696
-2% -$52.4K 0.01% 760
2026
Q1
$2.22M Buy
204,933
+95,068
+87% +$814K 0.02% 519
2025
Q4
$671K Sell
109,865
-141,525
-56% -$845K 0.01% 952
2025
Q3
$1.3M Sell
251,390
-421,456
-63% -$2.42M 0.01% 780
2025
Q2
$3.99M Buy
672,846
+491,251
+271% +$2.96M 0.02% 456
2025
Q1
$1.49M Buy
181,595
+19,832
+12% +$166K 0.01% 374
2024
Q4
$1.34M Buy
161,763
+131,624
+437% +$1.06M 0.01% 365
2024
Q3
$231K Buy
+30,139
New +$278K ﹤0.01% 947
2024
Q2
– Sell
-50,857
Closed -$607K – 1338
2024
Q1
$607K Buy
50,857
+18,785
+59% +$209K 0.01% 400
2023
Q4
$346K Buy
32,072
+21,999
+218% +$267K ﹤0.01% 654
2023
Q3
$139K Buy
+10,073
New +$147K ﹤0.01% 343

Other funds holding PTEN

Brevan Howard Capital Management's PTEN Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Patterson-UTI (PTEN) stake by 2.3% in Q2 2026, selling an estimated $52.4K and leaving 200,237 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #760.

Brevan Howard Capital Management first reported a position in PTEN in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.99M in Q2 2025. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Brevan Howard Capital Management held 200,237 shares of Patterson-UTI worth $1.84M as of Q2 2026.
  • Brevan Howard Capital Management sold 4,696 Patterson-UTI shares in Q2 2026, an estimated $52.4K.
  • Patterson-UTI made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #760 holding.
  • Brevan Howard Capital Management first reported a position in Patterson-UTI in Q3 2023 and has held it in 11 quarters since.
  • Brevan Howard Capital Management's Patterson-UTI position peaked at $3.99M in Q2 2025.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.